| |
PRZOOM - /newswire/ -
Los Angeles, CA, United States, 2025/06/19 - Recognition underscores Bruker’s commitment to sustainability and innovation in microbial detection - ASM.org / Bruker.com. NASDAQ: BRKR
|
| |
At the ASM Microbe 2025 conference (asm.org), Bruker today announced that its MALDI Biotyper® sirius and sirius one systems have been awarded the ACT Label, a mark of excellence in environmental accountability, consistency, and transparency. This independent certification evaluates sustainability across the instrument’s lifecycle - from production and daily operation to disposal. Achieving a low Environmental Impact Factor (EIF) score of 26.8 (EU and UK) and 35.4 (US), the MALDI Biotyper combines best-in-class performance in microbial identification while supporting environmentally responsible laboratory practices.
The ACT Label, issued by My Green Lab, serves as a trusted benchmark for sustainable lab equipment. This recognition affirms the MALDI Biotyper’s role in helping labs reduce their environmental footprint through smarter purchasing decisions.
"The ACT label marking of the MALDI Biotyper® systems represents a significant benchmark in our commitment to providing laboratories with sustainable solutions,” said Dr. Diana Kalinina, Director Product Management BA Microbiology. "It reflects our dedication to combining innovation with environmental responsibility, contributing to a greener future."
About Bruker Corporation
Bruker (bruker.com) is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics.
|
philip.perry[.]bruker.com 
